AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31162798
Drug: Gastrointestinal adverse
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gastrointestinal adverse events with Oliceridine 0.5 mg
Trial: 31162798
Drug: Oliceridine 0.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oliceridine 0.35 mg and 0.5 mg
Trial: 16538534
Drug: Raloxifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (60 or 600 mg daily for 2 weeks)
Trial: 8855737
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg and clarithromycin 250 mg (OC)
Trial: 8855737
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg, clarithromycin 250 mg, and metronidazole 500 mg (OCM)
Trial: 1281043
Drug: Internal radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internal radiation therapy by transcatheter hepatic arterial injection of [131I]‐Lp (group A)
Trial: 1281043
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of Lp‐TAE (group B)
Trial: 22920718
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR 50‐300 mg/day
Trial: 22920718
Drug: Divalproex ER
RxNorm normalized name: divalproex sodium Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divalproex ER 500‐3000 mg/day
Trial: 25511384
Drug: Ascophyllum nodosum
RxNorm normalized name: Ascophyllum nodosum
DrugBank: Ascophyllum nodosum (DB16591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ascophyllum nodosum (500 mg dried marine alga powder, ProDen PlaqueOff®)
Trial: 25511384
Drug: Negative control
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative control tablets
Trial: 3709647
Drug: Cisapride (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (8 mg)
Trial: 20514787
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CO2 fractional resurfacing and Kligman's formula maintenance topical cream (Group C)
Trial: 7734231
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment including hip and knee release, aponeurectomy of the iliotibial band, and z-shaped Achilles' tendon lengthening in group I (prophylactic treatment)
Trial: 7734231
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment including hip and knee release, aponeurectomy of the iliotibial band, and z-shaped Achilles' tendon lengthening in group II (treatment for existing contractures)
Trial: 22822019
Drug: Active spinal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active spinal anesthesia with fentanyl (25 μg, intrathecal L(3)‐L(4))
Trial: 16142016
Drug: Repaglinide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide (1 mg x 2/day)
Trial: 394563
Drug: Oral bromocriptine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bromocriptine (5 mg dd for 14 days)
Trial: 394563
Drug: Oral stilbestrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral stilbestrol (15 mg dd for 5 days)
Trial: 394563
Drug: Diuretic compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic compound (bendroflumethazide 15 mg dd for 5 days)
Trial: 23421781
Drug: Amoxycillin-clavulanate (22.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin-clavulanate (22.5 mg/kg twice daily)
Trial: 23421781
Drug: Azithromycin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (5 mg/kg daily)
Trial: 21878810
Drug: Intravenous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous treatment with ketamine
Trial: 21878810
Drug: Intravenous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous treatment with morphine
Trial: 11905957
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil diet (80 g corn oil/d)
Trial: 3067654
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg bromocriptine at bedtime
Trial: 16909787
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for TBE meningitis
Trial: 1482871
Drug: Computer-assisted interventions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted interventions (various types including reminder, feedback, dose planning, patient education, medical record)
Trial: 31248950
Drug: Esaxerenone 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esaxerenone 2.5 mg/d
Trial: 24502414
Drug: customary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: customary treatment plus active physiotherapy
Trial: 21058474
Drug: Acupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture and medication (Thiamazole and Euthyrox)
Trial: 12422105
Drug: Thigh-length sequential
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thigh-length sequential EPC devices (EPC)
Trial: 12422105
Drug: Subcutaneous heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous heparin injections (HEP)
Trial: 2038996
Drug: Naproxen (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (1000 mg daily for 7 days)
Trial: 2038996
Drug: Aspirin (3900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (3900 mg daily for 7 days)
Trial: 29420600
Drug: +50% precipitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: +50% precipitation treatment
Trial: 29420600
Drug: +33% precipitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: +33% precipitation treatment
Trial: 29420600
Drug: -50% precipitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: -50% precipitation treatment
Trial: 29420600
Drug: -33% precipitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: -33% precipitation treatment
Trial: 25244777
Drug: Ganfule prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganfule prescription combined with chemotherapy
Trial: 22307494
Drug: Oral essential
RxNorm normalized name: Eucalyptus essential oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral essential amino acids (EAAs) 8 g/d for 2 months
Trial: 17197463
Drug: Plain bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain bupivacaine 2.5 mg with fentanyl 15 microg
Trial: 17197463
Drug: Hyperbaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric bupivacaine 2.5 mg with fentanyl 15 microg
Trial: 9895184
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine to invigorate blood and relieve stasis
Trial: 28706262
Drug: Alcohol (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (1.5 g/l of body water)
Trial: 22128614
Drug: n‐3 polyunsaturated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n‐3 polyunsaturated fatty acids 2 g/day for at least 5 days before surgery and until hospital discharge
Trial: 17211567
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of multiple insulin injections and oral repaglinide (1.5 mgr tid)
Trial: 11420773
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg estradiol‐17 beta with cyclical dydrogesterone
Trial: 8325066
Drug: Inhaled piretanide
RxNorm normalized name: piretanide
DrugBank: Piretanide (DB02925)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled piretanide (12 mg)
Trial: 8325066
Drug: Inhaled piretanide
RxNorm normalized name: piretanide
DrugBank: Piretanide (DB02925)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled piretanide (24 mg)
Trial: 8325066
Drug: Inhaled piretanide
RxNorm normalized name: piretanide
DrugBank: Piretanide (DB02925)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled piretanide (48 mg)
Trial: 31864157
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (NAC) for ≤ 4 cycles (group 1)
Trial: 31864157
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (NAC) for ≥ 5 cycles (group 2)
Trial: 27991894
Drug: Fixed-dose IV
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose IV busulfan (130 mg/m2)
Trial: 21940527
Drug: PRECISION TACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRECISION TACE with drug-eluting beads (DEB)
Trial: 18177513
Drug: Rosiglitazone (RSG)
DrugBank: Rosiglitazone (DB00412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (RSG) 8 mg/d
Trial: 16456680
Drug: G+MET
RxNorm normalized name: Glimepiride + Metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G+MET
Trial: 15023878
Drug: Etanercept 25
RxNorm normalized name: etanercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 25 mg twice per week (RENAISSANCE)
Trial: 15023878
Drug: Etanercept 25
RxNorm normalized name: etanercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 25 mg weekly (RECOVER)
Trial: 15023878
Drug: Placebo (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (combined higher doses)
Trial: 22748747
Drug: FOR +
RxNorm normalized name: Gas for Inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOR + TIO (Formoterol 12 μg twice a day + Tiotropium 18 μg once a day)
Trial: 11432696
Drug: Citalopram 10
RxNorm normalized name: citalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 10 mg with Cyproheptadine (4 mg)
Trial: 7949021
Drug: Bromocriptine (BC)
DrugBank: Bromocriptine (DB01200)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bromocriptine (BC) treatment
Trial: 16463409
Drug: Prior use
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior use of psychiatric medications
Trial: 9174890
Drug: Edlan-plasty with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edlan-plasty with implants
Trial: 18328090
Drug: Lumiracoxib 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumiracoxib 100 mg once daily
Trial: 24850754
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control arm)
Trial: 27464970
Drug: Cixutumumab (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cixutumumab (20 mg/kg), Pemetrexed (500 mg/m2), Cisplatin (75 mg/m2)
Trial: 23456778
Drug: Chemotherapy (gemcitabine‐carboplatin)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (gemcitabine‐carboplatin)
Trial: 19629314
Drug: Usual medical
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual medical care and monthly telephone monitoring of administrative and epidemiological nature (Control Group)
Trial: 10686210
Drug: Org 31710
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 31710 (150 mg, every 28 days)
Trial: 9583332
Drug: Cognitive-Behavioral Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Treatment (CBT)
Trial: 31713710
Drug: Angiotensin receptor/neprilysin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin receptor/neprilysin inhibitor (ARNI)
Trial: 25303070
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no aquatic exercise, maintained normal treatments)
Trial: 24050577
Drug: S. officinalis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S. officinalis leaf extract (500 mg capsule t.i.d. for 3 months)
Trial: 11753809
Drug: Octreoid-Depot 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreoid-Depot 160 mg i.m. injection once a month plus 20 mg tamoxifen daily
Trial: 8388357
Drug: UF heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UF heparin (2 x 5,000 IU)
Trial: 24024838
Drug: 1.25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 g testosterone gel daily
Trial: 24024838
Drug: 2.5 g
RxNorm normalized name: Vaporizer 2.5 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g testosterone gel daily
Trial: 24024838
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g testosterone gel daily
Trial: 24024838
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g testosterone gel daily
Trial: 24024838
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel with anastrozole
Trial: 14519177
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus nicotine patch
Trial: 14519177
Drug: Oral selegiline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral selegiline plus nicotine patch
Trial: 10714415
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 100 mcg b.d.
Trial: 10714415
Drug: Zafirlukast 20
RxNorm normalized name: zafirlukast 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast 20 mg b.d.
Trial: 7968325
Drug: Caudal extradural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal extradural morphine group (n = 35)
Trial: 3569631
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (CT) (2 to 3 injections/day, self blood glucose monitoring)
Trial: 27433887
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment (CBT) for childhood anxiety disorders
Trial: 12453257
Drug: Not using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not using oral contraceptives
Trial: 8593716
Drug: 200 micrograms/cm2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 micrograms/cm2 of sphinganine in ethanol (50 microliters of a 1.6% solution)
Trial: 19775203
Drug: Saracatinib (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saracatinib (250 mg)
Trial: 41548
Drug: Dipotassium chlorazepate
RxNorm normalized name: Clorazepate Dipotassium
DrugBank: Clorazepic acid (DB00628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipotassium chlorazepate (15 mg)
Trial: 31023750
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration (WBV) training, twice a week for 12 weeks
Trial: 27839705
Drug: No heat-light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No heat-light (control) treatment
Trial: 8159441
Drug: Ketamine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (250 mcg/kg i.v. slow push)
Trial: 8159441
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous infusion of ketamine
Trial: 8159441
Drug: Single-dose injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose injections of ketamine
Trial: 3124047
Drug: Dantrolene sodium
RxNorm normalized name: Dantrolene Sodium
DrugBank: Dantrolene (DB01219)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dantrolene sodium (1.5 mg/kg per day)
Trial: 28815341
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa once weekly (QW)
Trial: 20135832
Drug: Topical lidocaine‐prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine‐prilocaine mixture
Trial: 20135832
Drug: No topical
RxNorm normalized name: Altreno Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No topical anesthesia (Control)
Trial: 18204342
Drug: Atomoxetine 80
RxNorm normalized name: atomoxetine 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 80 mg daily for 8 weeks
Trial: 15030297
Drug: Novel therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel therapies targeting post-translational endothelial and mesangial messengers
Trial: 8884309
Drug: Canrenoate potassium
RxNorm normalized name: canrenoate potassium
DrugBank: Canrenoic acid (DB09015)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canrenoate potassium (200mg in 10ml saline solution)
Trial: 8884309
Drug: Placebo (10ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (10ml saline solution)
Trial: 6851419
Drug: Chemical stimulation
RxNorm normalized name: follicle stimulating hormone / luteinizing hormone Injection [Menopur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemical stimulation (inhalation of citric acid)
Trial: 11394391
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (AB and AC)
Trial: 2500068
Drug: UFT-MMC therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT-MMC therapy (400 or 600 mg/day of UFT, plus 6 or 8 mg/body of MMC intravenously weekly for three weeks, then triweekly after six weeks)
Trial: 2500068
Drug: UFT-ACR therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT-ACR therapy (400 or 600 mg/day of UFT, plus 20 mg/body of ACR intravenously for 5 serial days every three weeks)
Trial: 7933495
Drug: New intraoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New intraoperative fluid infusion
Trial: 639574
Drug: Keratolytic gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Keratolytic gel treatment
Trial: 28708072
Drug: CF fortified
RxNorm normalized name: californium Cf-249
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CF fortified with 2 mg NaFeEDTA plus 3.8 mg FeFum for six days/week (n = 126)
Trial: 28708072
Drug: CF fortified
RxNorm normalized name: californium Cf-249
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CF fortified with 2 mg NaFeEDTA and 3.8 mg FePP for six days/week (n = 127)
Trial: 25864858
Drug: Silica-gold nanoparticles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silica-gold nanoparticles (NP) in a bioengineered on-artery patch
Trial: 15801015
Drug: Prasterone 200
RxNorm normalized name: prasterone 200 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasterone 200 mg/day
Trial: 11445487
Drug: High-dose isoxsuprine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose isoxsuprine hydrochloride (60 mg/day orally)
Trial: 7818725
Drug: Acarbose (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (3 x 50 mg day‐1 for days 1-3; 3 x 100 mg day‐1 for days 4-7)
Trial: 21844318
Drug: Vancomycin (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (125 mg q.i.d.)
Trial: 19552869
Drug: Pharmacologic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic and psychotherapeutic treatments
Trial: 15700744
Drug: Silver sulfadiazine
RxNorm normalized name: Silver Sulfadiazine
DrugBank: Silver sulfadiazine (DB05245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver sulfadiazine cream alone
Trial: 3919352
Drug: Nicotine-containing chewing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine-containing chewing gum (2.0 mg)
Trial: 29374780
Drug: Compression treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression treatment (N=82)
Trial: 18242722
Drug: ALN-RSV01 (150mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALN-RSV01 (150mg, single dose and for five daily doses)
Trial: 14515596
Drug: Paint-on gel
RxNorm normalized name: Castellani Paint
DrugBank: Phenol (DB03255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paint-on gel (18% carbamide peroxide)
Trial: 2029499
Drug: Unfiltered boiled
RxNorm normalized name: BOIL-EASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfiltered boiled coffee (lipid content, 1.0 g/l)
Trial: 19409693
Drug: Tadalafil (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil (all doses)
Trial: 8166152
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg BID
Trial: 21708030
Drug: eGFR below
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eGFR below 60 ml/min/1.73 m²
Trial: 17591648
Drug: PUFA (Arachidonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUFA (Arachidonic acid 240 mg/day, Docosahexaenoic acid 240 mg/day)